← Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.

A Hilario et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27026567